This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 11-14, 2026
Hynes Convention CenterBoston, MA

Takaki Habuchi, PhD
Research Associate at Nippon Shokubai
Speaker

Profile

Takaki Habuchi has been a researcher at NIPPON SHOKUBAI CO., LTD. since 2019, in charge of developing manufacturing processes for oligonucleotide APIs. His work focuses on improving these processes and scaling them up from laboratory-scale operations to large-scale production. He earned a master’s degree in 2019 in the Obika Laboratory at Osaka University and a doctorate in 2025 in the Wada Laboratory at Tokyo University of Science, conducting research on modified nucleic acids for antisense therapeutic applications. Across academia and industry, he has built a 10-year track record in nucleic acid chemistry.

Agenda Sessions

  • A Mild Cleavage and Deprotection Method for RNA Oligonucleotides Synthesized on Universal Supports

    10:20am